The PPARγ agonist efatutazone delays invasive progression and induces differentiation of ductal carcinoma in situ.
PPARγ激动剂efatutazone可延缓浸润性进展并诱导导管原位癌分化
期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-017-4649-y
Ory Virginie, Kietzman William B, Boeckelman Jacob, Kallakury Bhaskar V, Wellstein Anton, Furth Priscilla A, Riegel Anna T
